Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study
Rena C. Patel, Maricianah Onono, Monica Gandhi, et al.
The Lancet HIV (2015) Vol. 2, Iss. 11, pp. e474-e482
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
Antoinette T. Nguyen, Kathryn M. Curtis, Naomi K. Tepper, et al.
MMWR Recommendations and Reports (2024) Vol. 73, Iss. 4, pp. 1-126
Open Access | Times Cited: 45
Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks
Kimberly K. Scarsi, Kristin M. Darin, Shadia Nakalema, et al.
Clinical Infectious Diseases (2015) Vol. 62, Iss. 6, pp. 675-682
Open Access | Times Cited: 82
Drug interactions between hormonal contraceptives and antiretrovirals
Kavita Nanda, Gretchen S. Stuart, Jennifer Robinson, et al.
AIDS (2017) Vol. 31, Iss. 7, pp. 917-952
Open Access | Times Cited: 81
Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy
Maria Pyra, Renee Heffron, Nelly Mugo, et al.
AIDS (2015) Vol. 29, Iss. 17, pp. 2353-2359
Open Access | Times Cited: 51
Drug–Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV
Kimberly K. Scarsi, Kristin M. Darin, Catherine A. Chappell, et al.
Drug Safety (2016) Vol. 39, Iss. 11, pp. 1053-1072
Open Access | Times Cited: 47
Efavirenz decreases etonogestrel exposure
Catherine A. Chappell, Mohammed Lamorde, Shadia Nakalema, et al.
AIDS (2017) Vol. 31, Iss. 14, pp. 1965-1972
Open Access | Times Cited: 42
The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine
Megan Neary, Mohammed Lamorde, Adeniyi Olagunju, et al.
Clinical Pharmacology & Therapeutics (2017) Vol. 102, Iss. 3, pp. 529-536
Open Access | Times Cited: 30
Impact of ART on the fertility of HIV‐positive women in sub‐Saharan Africa
Sara Yeatman, Jeffrey W. Eaton, Zosia Beckles, et al.
Tropical Medicine & International Health (2016) Vol. 21, Iss. 9, pp. 1071-1085
Open Access | Times Cited: 28
Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines
Rena C. Patel, Chelsea Morroni, Kimberly K. Scarsi, et al.
Journal of the International AIDS Society (2017) Vol. 20, Iss. 1
Open Access | Times Cited: 27
Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users
Aaron Lazorwitz, Morgan Pena, Jeanelle Sheeder, et al.
Obstetrics and Gynecology (2022)
Open Access | Times Cited: 14
Current and future contraceptive options for women living with HIV
Rena C. Patel, Elizabeth A. Bukusi, Jared M. Baeten
Expert Opinion on Pharmacotherapy (2017) Vol. 19, Iss. 1, pp. 1-12
Open Access | Times Cited: 23
Strengthening implant provision and acceptance in South Africa with the ‘Any woman, any place, any time’ approach: An essential step towards reducing unintended pregnancies
Helen Rees, Yegan Pillay, Saiqa Mullick, et al.
South African Medical Journal (2017) Vol. 107, Iss. 11, pp. 939-939
Open Access | Times Cited: 22
Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study
Kimberly K. Scarsi, Yoninah Cramer, Susan L. Rosenkranz, et al.
The Lancet HIV (2019) Vol. 6, Iss. 9, pp. e601-e612
Open Access | Times Cited: 21
A randomized trial of double vs single-dose etonogestrel implant to overcome the interaction with efavirenz-based antiretroviral therapy
Catherine A. Chappell, Mohammed Lamorde, Shadia Nakalema, et al.
American Journal of Obstetrics and Gynecology (2024) Vol. 231, Iss. 2, pp. 242.e1-242.e9
Open Access | Times Cited: 2
Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug–drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART
Owain Roberts, Rajith K. R. Rajoli, David Back, et al.
Journal of Antimicrobial Chemotherapy (2017) Vol. 73, Iss. 4, pp. 1004-1012
Open Access | Times Cited: 17
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Journal of the International AIDS Society (2016) Vol. 19, pp. 21487-21487
Open Access | Times Cited: 15
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception
Jennifer E. Balkus, Thesla Palanee‐Phillips, Krishnaveni Reddy, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2017) Vol. 76, Iss. 2, pp. e47-e51
Open Access | Times Cited: 16
Levonorgestrel in contraceptives and multipurpose prevention technologies
Chelsea B. Polis, Sharon J. Phillips, Sharon L. Hillier, et al.
AIDS (2016) Vol. 30, Iss. 17, pp. 2571-2576
Open Access | Times Cited: 14
ACOG

Obstetrics and Gynecology (2016) Vol. 128, Iss. 4, pp. 1-1
Closed Access | Times Cited: 14
A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda
Rena C. Patel, Randy M. Stalter, Katherine K. Thomas, et al.
AIDS (2019) Vol. 33, Iss. 13, pp. 1995-2004
Open Access | Times Cited: 14
Reproductive intentions and family planning practices of pregnant HIV-infected Malawian women on antiretroviral therapy
Michele O’Shea, Nora E. Rosenberg, Jennifer H. Tang, et al.
AIDS Care (2016) Vol. 28, Iss. 8, pp. 1027-1034
Open Access | Times Cited: 13
Provider perspectives on contraceptive service delivery: findings from a qualitative study in Johannesburg, South Africa
Naomi Lince-Deroche, Cheryl Hendrickson, Aneesa Moolla, et al.
BMC Health Services Research (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 13
“I Found Out I was Pregnant, and I Started Feeling Stressed”: A Longitudinal Qualitative Perspective of Mental Health Experiences Among Perinatal Women Living with HIV
Emily L. Tuthill, Ann E. Maltby, Belinda C. Odhiambo, et al.
AIDS and Behavior (2021) Vol. 25, Iss. 12, pp. 4154-4168
Open Access | Times Cited: 12
The role of family planning in achieving safe pregnancy for serodiscordant couples: commentary from the United States government's interagency task force on family planning and HIV service integration
Jennifer Mason, Amy Medley, Sarah Yeiser, et al.
Journal of the International AIDS Society (2017) Vol. 20, Iss. S1
Open Access | Times Cited: 13
Interactions Between Hormonal Contraception and Anti-Retroviral Therapy: an Updated Review
Gopika Krishna, Lisa B. Haddad
Current Obstetrics and Gynecology Reports (2020) Vol. 9, Iss. 3, pp. 98-104
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top